Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol). (Q38255420)

1 September 2017

1 reference

title

Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol). (English)

1 reference

1 September 2017

1 reference

1 reference

Lingtak-Neander Chan

1

1 reference

1 September 2017

Gail D Anderson

series ordinal

2

1 reference

1 September 2017

language of work or name

1 reference

1 December 2014

1 reference

Clinical Pharmacokinetics

1 September 2017

1 reference

1 September 2017

53

1 reference

1 September 2017

1115-1136

1 reference

1 September 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1007/s40262-014-0190-x

1 September 2017

0 references

cites work

Role of variability in explaining ethanol pharmacokinetics: research and forensic applications

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Effect of 4-methylpyrazole on ethanol elimination rate and hepatic redox changes in alcoholics with adequate or inadequate nutrition and in nonalcoholic controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Pharmacokinetics of ethanol: a review of the methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Oxidative stress, toxicology, and pharmacology of CYP2E1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Pharmacokinetic parameters of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, after intravenous and oral administration of chlorzoxazone to liver cirrhotic rats with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Cytochrome P450 2E1 activity in diabetic and obese patients as assessed by chlorzoxazone hydroxylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Fasting for less than 24 h induces cytochrome P450 2E1 and 2B1/2 activities in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Characterization of cytochrome P450 2E1 induction in a rat hepatoma FGC-4 cell model by ethanol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Multiple mechanisms in the regulation of ethanol-inducible cytochrome P450IIE1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Alcohol consumption by aging adults in the United States: health benefits and detriments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Ethyl glucuronide-a biological marker for recent alcohol consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Gender differences in pharmacokinetics of alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Ethanol-induced coronary vasodilation in patients with and without coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Ethanol dilates coronary arteries and increases coronary flow via transient receptor potential vanilloid 1 and calcitonin gene-related peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Effects of ethanol on the contractile function of the heart: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Heavy alcohol consumption and risk of atrial fibrillation. The Circulatory Risk in Communities Study (CIRCS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Cytochromes P450 mediating the N-demethylation of amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

An evaluation of possible interactions between ethanol and trazodone or amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Amitriptyline and ethanol: pharmacokinetic and pharmacodynamic interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Effects of antidepressants on skilled performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Effects of zimeldine, mianserin and amitriptyline on psychomotor skills and their interaction with ethanol a placebo controlled cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Venlafaxine oxidation in vitro is catalysed by CYP2D6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Effect of ketoconazole on venlafaxine plasma concentrations in extensive and poor metabolisers of debrisoquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Clinical pharmacokinetics of retigabine/ezogabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

The effects of ethanol on the pharmacokinetics, pharmacodynamics, safety, and tolerability of ezogabine (retigabine).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

The acute effects of gabapentin in combination with alcohol in heavy drinkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Effect of short- and long-term alcohol use on phenytoin kinetics in chronic alcoholics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Benzodiazepine-like hypnotics and the associated risk of road traffic accidents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

The effects of alcohol on psychological functions in normal volunteers after 8 days' treatment with pipequaline (PK 8165), diazepam or placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Alcohol Interaction of Lormetazepam, Mepindolol Sulphate and Diazepam Measured by Performance on the Driving Simulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Effects of alcohol on buspirone and lorazepam actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Intravenous diazepam and oral ethanol interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Ethanol and oral diazepam absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Pharmacokinetic and pharmacodynamic interactions of bretazenil and diazepam with alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Kinetic and dynamic interaction of clobazam and alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

The glucuronidation of R- and S-lorazepam: human liver microsomal kinetics, UDP-glucuronosyltransferase enzyme selectivity, and inhibition by drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Effects of word frequency on recall memory following lorazepam, alcohol, and lorazepam alcohol interaction in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Effect of acute alcohol intoxication on the metabolism and plasma kinetics of chlordiazepoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Absorption of oral and intramuscular chlordiazepoxide by alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Decline in chlordiazepoxide plasma levels during fixed-dose therapy of alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Comparison of the effects of therapeutic doses of meptazinol and a dextropropoxyphene/paracetamol mixture alone and in combination with ethanol on ventilatory function and saccadic eye movements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Effect of concomitant ingestion of alcohol on the in vivo pharmacokinetics of KADIAN (morphine sulfate extended-release) capsules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Is development of hyperalgesia, allodynia and myoclonus related to morphine metabolism during long-term administration? Six case histories

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Cytochrome P450-mediated changes in oxycodone pharmacokinetics/pharmacodynamics and their clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Subjective, psychomotor, and physiological effects of oxycodone alone and in combination with ethanol in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Detection of the novel metabolite ethylphenidate after methylphenidate overdose with alcohol coingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Clinical pharmacokinetics of almotriptan, a serotonin 5-HT(1B/1D) receptor agonist for the treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Triazolam and ethanol interaction: kinetic and dynamic consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Effects of zaleplon or triazolam with or without ethanol on human performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Interaction between ethanol and calcium channel blockers in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Polymorphic acetylation of procainamide in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Ethanol-induced increase in procainamide acetylation in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Mitochondrial CYP2E1 is sufficient to mediate oxidative stress and cytotoxicity induced by ethanol and acetaminophen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Effect of ethanol on hepatotoxicity of acetaminophen in mice and on reactive metabolite formation by mouse and human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

The complex interaction between ethanol and acetaminophen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Pharmacokinetic interactions of alcohol and acetylsalicylic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Impact of gastric emptying on the pharmacokinetics of ethanol as influenced by cisapride

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Effect of luminal ethanol on epithelial resistances and cell volume in isolated Necturus gastric mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Pharmacokinetic studies of enantiomers of ibuprofen and its chiral metabolites in humans with different variants of genes coding CYP2C8 and CYP2C9 isoenzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Effect of histamine-2 receptor antagonists on blood alcohol levels: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Omeprazole, ranitidine, and cimetidine have no effect on peak blood ethanol concentrations, first pass metabolism or area under the time-ethanol curve under 'real-life' drinking conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Cytochrome P450 3A4 is the major enzyme involved in the metabolism of the substance P receptor antagonist aprepitant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Placebo- and amitriptyline-controlled evaluation of central nervous system effects of the NK1 receptor antagonist aprepitant and intravenous alcohol infusion at pseudo-steady state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

The pharmacokinetic-pharmacodynamic (Digit Symbol Substitution Test) relationship of flumazenil in a midazolam steady-state model in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Enhanced antithrombotic effect of warfarin associated with low-dose alcohol consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Lack of interaction between cefpirome and alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

An evaluation of potential mechanism-based inactivation of human drug metabolizing cytochromes P450 by monoamine oxidase inhibitors, including isoniazid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

The effects of acute ethanol intake on isoniazid pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Pharmacokinetic interaction of abacavir (1592U89) and ethanol in human immunodeficiency virus-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Interactions between alcohol and the antiretroviral medications ritonavir or efavirenz

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Maraviroc: in vitro assessment of drug-drug interaction potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Interactions between alcohol and the HIV entry inhibitor Maraviroc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

The effect of cannabidiol, alone and in combination with ethanol, on human performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Interaction of cannabidiol and alcohol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Ethanol increases plasma Delta(9)-tetrahydrocannabinol (THC) levels and subjective effects after marihuana smoking in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

The effect of cannabis compared with alcohol on driving

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Combined effects of acute, very-low-dose ethanol and delta(9)-tetrahydrocannabinol in healthy human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

The effect of alcohol, THC and their combination on perceived effects, willingness to drive and performance of driving and non-driving tasks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Purification and characterization of a human liver cocaine carboxylesterase that catalyzes the production of benzoylecgonine and the formation of cocaethylene from alcohol and cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Methamphetamine and ethanol interactions in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

The contributions of cytochromes P450 3A4 and 3A5 to the metabolism of the phosphodiesterase type 5 inhibitors sildenafil, udenafil, and vardenafil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS40262-014-0190-X

21 January 2018

12 December 2020

Interaction between marihuana and ethanol: effects on psychomotor performance

1 reference

12 December 2020

Effects of amitriptyline and zimelidine in combination with ethanol

1 reference

12 December 2020

Roles of cytochrome P4502C9 and cytochrome P4502C19 in the stereoselective metabolism of phenytoin to its major metabolite

1 reference

12 December 2020

Pharmacokinetics of [(14)C]abacavir, a human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitor, administered in a single oral dose to HIV-1-infected adults: a mass balance study

1 reference

12 December 2020

Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine

1 reference

12 December 2020

Formal genetics of isoniazid metabolism in man

1 reference

12 December 2020

Effects of fluvoxamine, alone and in combination with ethanol, on psychomotor and cognitive performance and on autonomic nervous system reactivity in healthy volunteers.

1 reference

12 December 2020

Benzodiazepine use and motor vehicle accidents. Systematic review of reported association

1 reference

12 December 2020

Aspirin attenuation of alcohol-induced flushing and intoxication in Oriental and Occidental subjects

1 reference

12 December 2020

Effects of the menstrual cycle of white women on ethanol toxicokinetics.

1 reference

12 December 2020

Human gastric alcohol dehydrogenase: its inhibition by H2-receptor antagonists, and its effect on the bioavailability of ethanol

1 reference

12 December 2020

The acute effects of zolpidem, administered alone and with alcohol, on cognitive and psychomotor function.

1 reference

12 December 2020

Interactions of alcohol with amitriptyline, fluoxetine and placebo in normal subjects.

1 reference

12 December 2020

Ranitidine increases the bioavailability of imbibed alcohol by accelerating gastric emptying

1 reference

12 December 2020

Effects of diazepam, chlordiazepoxide, thioridazine, haloperidole, flupenthixole and alcohol on psychomotor skills related to driving

1 reference

12 December 2020

Mechanism of the aspirin-induced rise in blood alcohol levels

1 reference

12 December 2020

Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failure

1 reference

12 December 2020

Quinolone inhibition of cytochrome P-450-dependent caffeine metabolism in human liver microsomes

1 reference

12 December 2020

Significant increase of blood alcohol by cimetidine after repetitive drinking of small alcohol doses

1 reference

12 December 2020

The additive effects of alcohol and benzodiazepines on driving.

1 reference

12 December 2020

Aspirin increases blood alcohol concentrations in humans after ingestion of ethanol

1 reference

12 December 2020

Amoxicillin kinetics and ethanol ingestion

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic evaluation of the potential drug interaction between venlafaxine and ethanol

1 reference

12 December 2020

Liver disease selectively modulates cytochrome P450--mediated metabolism

1 reference

12 December 2020

Effects of buspirone and diazepam, alone and in combination with alcohol, on skilled performance and evoked potentials.

1 reference

12 December 2020

Marihuana attenuates the rise in plasma ethanol levels in human subjects

1 reference

12 December 2020

Influence of ethanol on cannabinoid pharmacokinetic parameters in chronic users

1 reference

12 December 2020

Alcohol and bupropion pharmacokinetics in healthy male volunteers

1 reference

12 December 2020

Effects of acute alcohol infusion on duration and dispersion of QT interval in male patients with coronary artery disease and in healthy controls

1 reference

12 December 2020

Ethanol inhibition of codeine and morphine metabolism in isolated rat hepatocytes

1 reference

12 December 2020

Mechanisms behind the inhibitory effect of ethanol on the conjugation of morphine in rat hepatocytes.

1 reference

12 December 2020

Erythromycin: a motilin agonist and gastrointestinal prokinetic agent

1 reference

12 December 2020

The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants

1 reference

12 December 2020

Enzymology of ethanol and acetaldehyde metabolism in mammals

1 reference

12 December 2020

Divergence of ethanol and acetaldehyde kinetics and of the disulfiram-alcohol reaction between subjects with and without alcoholic liver disease

1 reference

12 December 2020

Enhancement of propoxyphene bioavailability by ethanol. Relation to psychomotor and cognitive function in healthy volunteers

1 reference

12 December 2020

Reduced Concentrations of Plasma Diazepam in Chronic Alcoholic Patients Following an Oral Administration of Diazepam

1 reference

12 December 2020

In vitro characterization of clobazam metabolism by recombinant cytochrome P450 enzymes: importance of CYP2C19.

1 reference

12 December 2020

Less glucuronidation of morphine in the presence of ethanol in vivo

1 reference

12 December 2020

Fluvoxamine does not interact with alcohol or potentiate alcohol-related impairment of cognitive function

1 reference

12 December 2020

Pretreatment with hydromorphone, a mu-opioid agonist, does not alter the acute behavioral and physiological effects of ethanol in humans

1 reference

12 December 2020

Effects of ranitidine on blood alcohol levels after ethanol ingestion. Comparison with other H2-receptor antagonists

1 reference

12 December 2020

The "holiday heart": electrophysiologic studies of alcohol effects in alcoholics

1 reference

12 December 2020

Ethanol does not significantly affect the bioavailability of almotriptan: an open, randomized, crossover, single-dose, phase I clinical trial in healthy volunteers

1 reference

12 December 2020

Influence of ethanol on the pharmacokinetics of methylphenidate's metabolites ritalinic acid and ethylphenidate

1 reference

12 December 2020

No influence of ciprofloxacin on ethanol disposition. A pharmacokinetic-pharmacodynamic interaction study

1 reference

12 December 2020

Identification of the human and rat P450 enzymes responsible for the sulfoxidation of S-methyl N,N-diethylthiolcarbamate (DETC-ME). The terminal step in the bioactivation of disulfiram

1 reference

12 December 2020

Warfarin pharmacogenetics

1 reference

12 December 2020

Simulated Car Driving as a Useful Technique for the Determination of Residual Effects and Alcohol Interaction After Short- and Long-Acting Benzodiazepines

1 reference

12 December 2020

Acute alcohol consumption is associated with increased interatrial electromechanical delay in healthy men

1 reference

12 December 2020

Ethylphenidate formation in human subjects after the administration of a single dose of methylphenidate and ethanol

1 reference

12 December 2020

The interaction of ethanol and delta9-tetrahydrocannabinol in man: effects on perceptual, cognitive and motor functions

1 reference

12 December 2020

Pharmacokinetics of gabapentin in subjects with various degrees of renal function

1 reference

12 December 2020

Identification of human cytochrome P450 enzymes involved in the major metabolic pathway of fluvoxamine

1 reference

12 December 2020

The interaction of the lipase inhibitor orlistat with ethanol in healthy volunteers

1 reference

12 December 2020

Effects of various concomitant medications on gastric alcohol dehydrogenase and the first-pass metabolism of ethanol

1 reference

12 December 2020

Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation

1 reference

12 December 2020

Effect of ranitidine hydrochloride (150 mg twice daily) on the pharmacokinetics of increasing doses of ethanol (0.15, 0.3, 0.6 g kg-1)

1 reference

12 December 2020

Translational activation of ethanol-inducible cytochrome P450 (CYP2E1) by isoniazid

1 reference

12 December 2020

The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption

1 reference

12 December 2020

Kinetic interactions between 4-methylpyrazole and ethanol in healthy humans

1 reference

12 December 2020

Human and Animal Study on Elimination from Plasma and Metabolism of Diazepam after Chronic Alcohol Intake

1 reference

12 December 2020

Effects of delta-9-tetrahydrocannabinol on drug distribution and metabolism. Antipyrine, pentobarbital, and ethanol

1 reference

12 December 2020

Comparison of drug concentrations between whole blood and oral fluid.

1 reference

12 December 2020

Ethanol enhances the hemodynamic effects of felodipine.

1 reference

12 December 2020

Increased Rate of Clearance of Drugs from the Circulation of Alcoholics*

1 reference

12 December 2020

Influence of alcohol consumption on erythromycin ethylsuccinate kinetics

1 reference

12 December 2020

Pharmacokinetics of morphine and its glucuronides after intravenous infusion of morphine and morphine-6-glucuronide in healthy volunteers*

1 reference

12 December 2020

Effect of an acute dose of alcohol on the pharmacokinetics of oral nifedipine in humans

1 reference

12 December 2020

Benzodiazepines and ethanol: assessment of the effects and consequences of psychotropic drug interactions

1 reference

12 December 2020

Effects of pregnancy and nutritional status on alcohol metabolism.

1 reference

12 December 2020

Influence of ethanol ingestion on tetracycline kinetics

1 reference

12 December 2020

Influence of ethanol on the pharmacokinetic properties of Δ9-tetrahydrocannabinol in oral fluid

1 reference

12 December 2020

Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity.

1 reference

12 December 2020

The effect of ibuprofen on ethanol concentration and elimination rate

1 reference

12 December 2020

Hypertension and chronic ethanol consumption: What do we know after a century of study?

1 reference

12 December 2020

Actions and interactions of hypnotics on human performance: single doses of zopiclone, triazolam and alcohol

1 reference

12 December 2020

Effect of short-term ethanol administration on lorazepam clearance

1 reference

12 December 2020

Carbamazepine kinetics and adverse effects during and after ethanol exposure in alcoholics and in healthy volunteers

1 reference

12 December 2020

Pharmacokinetic Noninteraction of Triazolam and Ethanol

1 reference

12 December 2020

Ethanol and the absorption of oral penicillin in man

1 reference

12 December 2020

Metabolism of the human immunodeficiency virus protease inhibitors indinavir and ritonavir by human intestinal microsomes and expressed cytochrome P4503A4/3A5: mechanism-based inactivation of cytochrome P4503A by ritonavir.

1 reference

12 December 2020

Simultaneous administration of vardenafil and alcohol does not result in a pharmacodynamic or pharmacokinetic interaction in healthy male subjects

1 reference

12 December 2020

The influences of age and gender on blood ethanol concentrations in healthy humans

1 reference

12 December 2020

Dose-effect relationship of disulfiram in human volunteers. II: A study of the relation between the disulfiram-alcohol reaction and plasma concentrations of acetaldehyde, diethyldithiocarbamic acid methyl ester, and erythrocyte aldehyde dehydrogenas

1 reference

12 December 2020

Verapamil inhibits ethanol elimination and prolongs the perception of intoxication

1 reference

12 December 2020

Effect of cigarette smoking on fluvoxamine pharmacokinetics in humans

1 reference

12 December 2020

Cytochrome P-4502E1: its physiological and pathological role

1 reference

12 December 2020

Cocaine and alcohol interactions in humans: neuroendocrine effects and cocaethylene metabolism.

1 reference

12 December 2020

Alcohol ingestion lowers supine blood pressure, causes splanchnic vasodilatation and worsens postural hypotension in primary autonomic failure

1 reference

12 December 2020

10.1007/S40262-014-0190-X

Identifiers

DOI

1 reference

Dimensions Publication ID

1 September 2017

0 references

1 reference